Jay Singh

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia

G. Sharma, S. Bakhshi, P. Chattopadhyay, 2021, Frontiers in Oncology.

Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights

V. Scaria, S. Kapoor, S. Sivasubbu, 2024, PNAS nexus.

Molecular Biology of B- and T-ALL

A. Chopra, Rajive Kumar, J. Singh, 2019, Hematopathology.

Rituximab added to standard chemotherapy and its effect on minimal residual disease during induction in CD20 positive pediatric acute lymphoblastic leukemia: a pilot RCT.

R. Pandey, S. Bakhshi, R. Seth, 2021, American journal of blood research.

High SPAG5 Expression Is Associated With Oncological Features in Endometrial Carcinoma

S. S. Chauhan, J. Palanichamy, A. Chopra, 2021 .

Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma

S. S. Chauhan, S. Kumari, R. Yadav, 2021, Frontiers in Molecular Biosciences.

RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia

D. Rao, S. Bakhshi, J. Singh, 2023, Journal of Experimental & Clinical Cancer Research.

Non-coding RNA in idiopathic interstitial pneumonia and Covid-19 pulmonary fibrosis

D. Mitra, A. Bhalla, V. Hadda, 2022, Molecular Biology Reports.